AC
ALXN
Armistice Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-500,000
| Closed | -$57.2M | – | 132 |
|
|
2020
Q3 | $57.2M | Hold |
500,000
| – | – | 2.08% | 8 |
|
|
2020
Q2 | $56.1M | Buy |
500,000
+72,000
| +17% | +$8.08M | 2.46% | 5 |
|
|
2020
Q1 | $38.4M | Buy |
428,000
+360,000
| +529% | +$32.3M | 2.38% | 8 |
|
|
2019
Q4 | $7.35M | Buy |
+68,000
| New | +$7.35M | 0.42% | 56 |
|
|
2019
Q1 | – | Sell |
-124,000
| Closed | -$12.1M | – | 92 |
|
|
2018
Q4 | $12.1M | Buy |
+124,000
| New | +$12.1M | 0.92% | 23 |
|
|
2018
Q3 | – | Sell |
-112,000
| Closed | -$13.9M | – | 89 |
|
|
2018
Q2 | $13.9M | Buy |
+112,000
| New | +$13.9M | 0.91% | 28 |
|
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$12.2M | – | 71 |
|
|
2017
Q2 | $12.2M | Sell |
100,000
-6,000
| -6% | -$730K | 1.55% | 19 |
|
|
2017
Q1 | $12.9M | Buy |
+106,000
| New | +$12.9M | 2.65% | 12 |
|